278 related articles for article (PubMed ID: 36016551)
1. Interacting binding insights and conformational consequences of the differential activity of cannabidiol with two endocannabinoid-activated G-protein-coupled receptors.
Dávila EM; Patricio F; Rebolledo-Bustillo M; Garcia-Gomez D; Hernandez JCG; Sanchez-Gaytan BL; Limón ID; Perez-Aguilar JM
Front Pharmacol; 2022; 13():945935. PubMed ID: 36016551
[TBL] [Abstract][Full Text] [Related]
2. Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors.
Tham M; Yilmaz O; Alaverdashvili M; Kelly MEM; Denovan-Wright EM; Laprairie RB
Br J Pharmacol; 2019 May; 176(10):1455-1469. PubMed ID: 29981240
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological profiling of the hemodynamic effects of cannabinoid ligands: a combined in vitro and in vivo approach.
Walsh SK; Hepburn CY; Keown O; Åstrand A; Lindblom A; Ryberg E; Hjorth S; Leslie SJ; Greasley PJ; Wainwright CL
Pharmacol Res Perspect; 2015 Jun; 3(3):e00143. PubMed ID: 26236485
[TBL] [Abstract][Full Text] [Related]
4. Motor effects of the non-psychotropic phytocannabinoid cannabidiol that are mediated by 5-HT1A receptors.
Espejo-Porras F; Fernández-Ruiz J; Pertwee RG; Mechoulam R; García C
Neuropharmacology; 2013 Dec; 75():155-63. PubMed ID: 23924692
[TBL] [Abstract][Full Text] [Related]
5. Allosteric Modulation of the CB1 Cannabinoid Receptor by Cannabidiol-A Molecular Modeling Study of the N-Terminal Domain and the Allosteric-Orthosteric Coupling.
Jakowiecki J; Abel R; Orzeł U; Pasznik P; Preissner R; Filipek S
Molecules; 2021 Apr; 26(9):. PubMed ID: 33922473
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB
Navarro G; Varani K; Lillo A; Vincenzi F; Rivas-Santisteban R; Raïch I; Reyes-Resina I; Ferreiro-Vera C; Borea PA; Sánchez de Medina V; Nadal X; Franco R
Pharmacol Res; 2020 Sep; 159():104940. PubMed ID: 32470563
[TBL] [Abstract][Full Text] [Related]
7. Increase of mesenchymal stem cell migration by cannabidiol via activation of p42/44 MAPK.
Schmuhl E; Ramer R; Salamon A; Peters K; Hinz B
Biochem Pharmacol; 2014 Feb; 87(3):489-501. PubMed ID: 24304686
[TBL] [Abstract][Full Text] [Related]
8. N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor.
McHugh D; Hu SS; Rimmerman N; Juknat A; Vogel Z; Walker JM; Bradshaw HB
BMC Neurosci; 2010 Mar; 11():44. PubMed ID: 20346144
[TBL] [Abstract][Full Text] [Related]
9. A role for O-1602 and G protein-coupled receptor GPR55 in the control of colonic motility in mice.
Li K; Fichna J; Schicho R; Saur D; Bashashati M; Mackie K; Li Y; Zimmer A; Göke B; Sharkey KA; Storr M
Neuropharmacology; 2013 Aug; 71(100):255-63. PubMed ID: 23603203
[TBL] [Abstract][Full Text] [Related]
10. Dual allosteric and orthosteric pharmacology of synthetic analog cannabidiol-dimethylheptyl, but not cannabidiol, on the cannabinoid CB
Bouma J; Broekhuis JD; van der Horst C; Kumar P; Ligresti A; van der Stelt M; Heitman LH
Biochem Pharmacol; 2023 Dec; 218():115924. PubMed ID: 37972874
[TBL] [Abstract][Full Text] [Related]
11. Antidepressant-like effect of cannabidiol injection into the ventral medial prefrontal cortex-Possible involvement of 5-HT1A and CB1 receptors.
Sartim AG; Guimarães FS; Joca SR
Behav Brain Res; 2016 Apr; 303():218-27. PubMed ID: 26801828
[TBL] [Abstract][Full Text] [Related]
12. Interaction of Synthetic Cannabinoid Receptor Agonists with Cannabinoid Receptor I: Insights into Activation Molecular Mechanism.
Gavryushov S; Bashilov A; Cherashev-Tumanov KV; Kuzmich NN; Burykina TI; Izotov BN
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834323
[TBL] [Abstract][Full Text] [Related]
13. THC Reduces Ki67-Immunoreactive Cells Derived from Human Primary Glioblastoma in a GPR55-Dependent Manner.
Kolbe MR; Hohmann T; Hohmann U; Ghadban C; Mackie K; Zöller C; Prell J; Illert J; Strauss C; Dehghani F
Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33802282
[TBL] [Abstract][Full Text] [Related]
14. GPR55: a new member of the cannabinoid receptor clan?
Pertwee RG
Br J Pharmacol; 2007 Dec; 152(7):984-6. PubMed ID: 17876300
[TBL] [Abstract][Full Text] [Related]
15. Cannabidiol-induced panicolytic-like effects and fear-induced antinociception impairment: the role of the CB
Khan AU; Falconi-Sobrinho LL; Dos Anjos-Garcia T; de Fátima Dos Santos Sampaio M; de Souza Crippa JA; Menescal-de-Oliveira L; Coimbra NC
Psychopharmacology (Berl); 2020 Apr; 237(4):1063-1079. PubMed ID: 31919563
[TBL] [Abstract][Full Text] [Related]
16. Cannabidiol disrupts the consolidation of specific and generalized fear memories via dorsal hippocampus CB
Stern CAJ; da Silva TR; Raymundi AM; de Souza CP; Hiroaki-Sato VA; Kato L; Guimarães FS; Andreatini R; Takahashi RN; Bertoglio LJ
Neuropharmacology; 2017 Oct; 125():220-230. PubMed ID: 28754373
[TBL] [Abstract][Full Text] [Related]
17. Are cannabidiol and Δ(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review.
McPartland JM; Duncan M; Di Marzo V; Pertwee RG
Br J Pharmacol; 2015 Feb; 172(3):737-53. PubMed ID: 25257544
[TBL] [Abstract][Full Text] [Related]
18. Medial prefrontal cortex mechanisms of cannabidiol-induced aversive memory reconsolidation impairments.
Bayer H; Stern CAJ; Troyner F; Gazarini L; Guimarães FS; Bertoglio LJ
Neuropharmacology; 2022 Mar; 205():108913. PubMed ID: 34864001
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors.
Járai Z; Wagner JA; Varga K; Lake KD; Compton DR; Martin BR; Zimmer AM; Bonner TI; Buckley NE; Mezey E; Razdan RK; Zimmer A; Kunos G
Proc Natl Acad Sci U S A; 1999 Nov; 96(24):14136-41. PubMed ID: 10570211
[TBL] [Abstract][Full Text] [Related]
20. Antinociceptive effects of HUF-101, a fluorinated cannabidiol derivative.
Silva NR; Gomes FV; Fonseca MD; Mechoulam R; Breuer A; Cunha TM; Guimarães FS
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):369-377. PubMed ID: 28720466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
